AHealthyMe
-
Login Registration Sample personal Change Profile Log Out
Search AHealthyMe!  
Personalize AHealthyMe! -Sign up for our Newsletter!

Women's HealthMen's HealthHelath After 60Children's HealthPregnancyFitness & NutritionAlternative HealthLifestyle & WellnessWork & HealthIlls & ConditionsDental HealthSelf-Care CentersMedical LibraryCool ToolsMultimediaEn Español-

Blue Cross Blue Shield of Massachusetts

You are here: Home > Health A to Z > Primary lymphoma of the brain



Related topics:
•  Cancer

Primary lymphoma of the brain

Definition
Signs and tests
Alternative Names
Treatment
Causes, incidence, and risk factors
Expectations (prognosis)
Symptoms
Complications


Brain
Brain

 Definition  

Primary lymphoma of the brain is cancer that started in the brain.

 Alternative Names  

Brain lymphoma; Cerebral lymphoma; Primary lymphoma of the central nervous system; Lymphoma - brain

 Causes, incidence, and risk factors  

The cause of primary brain lymphoma is unknown, but it is more common in people between the ages of 45 and 70. Patients who are immunocompromised, such those with HIV or organ transplants, especially heart transplants, are at greater risk for primary lymphoma of the brain. In immunocompromised patients, the lymphoma is linked to Epstein Barr Virus (EBV) infection.

The incidence is rising, but primary brain lymphoma is still relatively rare.

 Symptoms  

  • Personality changes
  • Confusion
  • Changes in speech
  • Changes in vision
  • Weakness in hands
  • Numbness to hot, cold, and pain
  • Headaches
  • Seizures
  • Hallucinations

 Signs and tests  

The following tests may be performed to help diagnose a primary lymphoma of the brain:

  • Biopsy of the brain -- shows lymphoma
  • Head CT scan -- shows a brain lesion
  • CSF total protein -- high
  • CSF cell count -- shows increased white blood cells or lymphoma cells

 Treatment  

The initial treatment is usually with corticosteroids. However, chemotherapy increases survival in many individuals up to 3-4 years, or longer. The chemotherapy is primarily high-dose methotrexate given intravenously or via the spinal cord.

Treatment of immunocompromised patients is not as successful, but is improving.

Radiation therapy used to be the main treatment for this lymphoma, but now is usually reserved for treating those patients in whom chemotherapy is not successful.

 Expectations (prognosis)  

The survival of untreated primary brain lymphoma is under 2 months. Treated with chemotherapy, patients often survive 3-4 years or more. About 40% of patients are alive at 5 years. In general, older patients have a worse outlook than younger patients.

 Complications  

Possible complications include:

  • Radiation side effects, including confusion, headaches, neurologic problems, and tissue death
  • Chemotherapy side effects, including low blood counts
  • Recurrence of the lymphoma

Review date: 9/27/2006

Reviewed By: William Matsui, MD, Assistant Professor of Oncology, Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.